<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chattopadhyay A</submitter><funding>NHLBI</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>U.S. Public Health Service</funding><funding>National Institutes of Health</funding><funding>University of California, Los Angeles</funding><funding>U.S. Department of Veterans Affairs</funding><funding>CSRD VA</funding><pagination>100370</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10200992</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>64(5)</volume><pubmed_abstract>Conversion of lysophosphatidylcholine to lysophosphatidic acid (LPA) by autotaxin, a secreted phospholipase D, is a major pathway for producing LPA. We previously reported that feeding Ldlr&lt;sup>-/-&lt;/sup> mice standard mouse chow supplemented with unsaturated LPA or lysophosphatidylcholine qualitatively mimicked the dyslipidemia and atherosclerosis induced by feeding a Western diet (WD). Here, we report that adding unsaturated LPA to standard mouse chow also increased the content of reactive oxygen species and oxidized phospholipids (OxPLs) in jejunum mucus. To determine the role of intestinal autotaxin, enterocyte-specific Ldlr&lt;sup>-/-&lt;/sup>/Enpp2 KO (intestinal KO) mice were generated. In control mice, the WD increased enterocyte Enpp2 expression and raised autotaxin levels. Ex vivo, addi</pubmed_abstract><journal>Journal of lipid research</journal><pubmed_title>Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis.</pubmed_title><pmcid>PMC10200992</pmcid><funding_grant_id>CDA2 IK2CX001717</funding_grant_id><funding_grant_id>IK2 CX001717</funding_grant_id><funding_grant_id>1R01 HL148286</funding_grant_id><funding_grant_id>P30 DK041301</funding_grant_id><pubmed_authors>Sulaiman D</pubmed_authors><pubmed_authors>Moolenaar WH</pubmed_authors><pubmed_authors>Jacobs JP</pubmed_authors><pubmed_authors>Delk S</pubmed_authors><pubmed_authors>Reddy ST</pubmed_authors><pubmed_authors>Navab M</pubmed_authors><pubmed_authors>Mukherjee P</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Dorreh N</pubmed_authors><pubmed_authors>Fogelman AM</pubmed_authors><pubmed_authors>Chattopadhyay A</pubmed_authors><pubmed_authors>Girjalva V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis.</name><description>Conversion of lysophosphatidylcholine to lysophosphatidic acid (LPA) by autotaxin, a secreted phospholipase D, is a major pathway for producing LPA. We previously reported that feeding Ldlr&lt;sup>-/-&lt;/sup> mice standard mouse chow supplemented with unsaturated LPA or lysophosphatidylcholine qualitatively mimicked the dyslipidemia and atherosclerosis induced by feeding a Western diet (WD). Here, we report that adding unsaturated LPA to standard mouse chow also increased the content of reactive oxygen species and oxidized phospholipids (OxPLs) in jejunum mucus. To determine the role of intestinal autotaxin, enterocyte-specific Ldlr&lt;sup>-/-&lt;/sup>/Enpp2 KO (intestinal KO) mice were generated. In control mice, the WD increased enterocyte Enpp2 expression and raised autotaxin levels. Ex vivo, addi</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-04T10:27:32.042Z</modification><creation>2025-04-04T10:27:32.042Z</creation></dates><accession>S-EPMC10200992</accession><cross_references><pubmed>37059333</pubmed><doi>10.1016/j.jlr.2023.100370</doi></cross_references></HashMap>